ExpreS2ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement

News   Jun 11, 2013

 
ExpreS<sup>2</sup>ion Biotechnologies and Cancer Research UK Enter a Licensing Agreement
 
 
 

RELATED ARTICLES

Computational Model Underlines Need for Personalised Approach to Sepsis

News

A computational model of the human immune system has enabled researchers to explore the challenges of tackling sepsis.

READ MORE

FoxO Proteins Implicated in Arthritis Age Risk

News

A study examining osteoarthritis has shown that as joints age, levels of FoxO decrease, causing pain and inflammation.

READ MORE

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE